|
May 1
|
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
|
|
Apr 30
|
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
|
|
Apr 29
|
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
|
|
Apr 27
|
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Apr 26
|
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
|
|
Apr 26
|
Q1 2024 Gilead Sciences Inc Earnings Call
|
|
Apr 26
|
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
|
|
Apr 26
|
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
|
|
Apr 26
|
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
|
|
Apr 25
|
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 25
|
Gilead Beats Earnings Expectations After Rocky Quarter
|
|
Apr 25
|
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
|
|
Apr 25
|
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
|
|
Apr 25
|
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
|
|
Apr 25
|
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
|
|
Apr 25
|
Gilead Sciences Announces First Quarter 2024 Financial Results
|
|
Apr 24
|
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
|
|
Apr 23
|
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
|
|
Apr 22
|
Undervalued Icons: 3 Household Names Trading at Steep Discounts
|
|
Apr 22
|
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
|